Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Salkind Gene, Director. Director active across 2 companies, notably Mobiquity Technologies, Inc.. Aggregated, 14 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €31k. Activity tracked since 30 March 2022. The latest transaction was disclosed on 11 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Salkind Gene
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Salkind Gene is Administrateur at Mobiquity Technologies, Inc. and Coeptis Therapeutics Holdings, Inc. He has 14 filings in total, and across the 14 sampled filings, the activity covered runs from 2021-10-04 to 2026-02-13, with EUR 31,443 of buys and EUR 0 of sells, and the modal transaction nature is Attribution.